Polymyostis initiation involving amlodipine besylate
Golding, R.M., Giles, L.G.F., and Sokoya, E.M. (2006) Polymyostis initiation involving amlodipine besylate. American Journal of Immunology, 2 (1). pp. 19-22.
![[img]](http://eprints.jcu.edu.au/style/images/fileicons/application_pdf.png) | PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader 101Kb |
View at Publisher Website: http://www.scipub.org/fulltext/aji/aji21...
Abstract
[Extract] Based on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis the evidence suggests that the polymyositis in a particular patient was initiated by taking the drug amlodipine besylate (norvasc). The method of our analysis should serve as a foundation in handling other drug related interactions.
| ID Code: | 4148 |
|---|---|
| Item Type: | Article (Refereed Research - C1) |
| Related URLs: | |
| Keywords: | polymyositis; amlodipine besylate; toxicity; adverse drug reaction; blood pressure; steroid therapy |
| FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1199 Other Medical and Health Sciences > 119999 Medical and Health Sciences not elsewhere classified @ 100% |
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920116 Skeletal System and Disorders (incl. Arthritis) @ 100% |
| Deposited On: | 04 Nov 2009 10:21 |
| Last Modified: | 02 Nov 2012 09:11 |
| Downloads: | Total: 1 Last 12 Months: 0 |
| Statistics: | More Statistics |
Repository Staff Only: item control page